Table 4.
Mean costs and psychosocial functioning
|
Step-down condition |
Outpatient condition |
|||||||
|---|---|---|---|---|---|---|---|---|
|
Costs |
GAF |
Costs |
GAF |
|||||
| n | Mean (SD) | Median | Mean (SD) | n | Mean (SD) | Median | Mean (SD) | |
| Costs: The year before trial |
45 |
844 (1793) |
160 |
47 (4) |
46 |
1406 (2604) |
370 |
48 (5) |
| GAF: 0 months | ||||||||
| Costs: First 0–8-month period |
52 |
1462 (854) |
1325 |
51 (10) |
46 |
1294 (3034) |
536 |
50 (12) |
| GAF: 8 months | ||||||||
| Costs: 9–18-month period |
47 |
618 (806) |
496 |
53 (10) |
37 |
944 (1771) |
368 |
57 (12) |
| GAF: 18 months | ||||||||
| Costs: Last 19–36-month period |
45 | 794 (1128) | 474 | 57 (12)* | 36 | 407 (620) | 270 | 67 (13)* |
| GAF: 36 months | ||||||||
The table demonstrates mean monthly costs (€) per patient (treatment and additional health services) for each assessment period and global functioning (GAF) scores at baseline (0) and after 8, 18, and 36 months. Statistically significant differences between the outpatient and step-down condition are marked with an asterisk (* = P < 0.05, independent-samples t-tests).